Bevidox

Quick links to important sections

Bevidox

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bevidox

Property Description
Active Ingredients Thiamine (Vitamin B1), Pyridoxine (Vitamin B6), Cyanocobalamin or Hydroxocobalamin (Vitamin B12)
Forms Solution for injection, Oral tablet
Pharmacological Class Neurotropic agent, Vitamin-mineral complex
Origin Synthetic/Derived
General Purpose Supports nervous system health and function

What Type of Medicine is Bevidox?

Bevidox is a pharmaceutical preparation classified as a combination B-vitamin preparation and a specific vitamin-mineral complex, distinguishing it from general daily supplements. Due to the targeted action of its components on neural tissue, it is specifically classified as a neurotropic agent. This combination drug contains three distinct, synthetic/derived water-soluble vitamins and is typically formulated for high-dose administration. It is commonly marketed for use in managing situations where the nervous system requires supplementary nutritional support, a need clinically recognized in various settings.

Composition: What Essential Nutrients Are in Bevidox?

The product contains a fixed-dose combination of three essential micronutrients: Thiamine (Vitamin B1), Pyridoxine (Vitamin B6), and Cyanocobalamin or Hydroxocobalamin (Vitamin B12). These are the core active ingredients needed for proper biological function, typically prepared in an aqueous solution for injection or as an oral tablet. This combination supports nerve cell metabolism and function. As a targeted product, the specific ratio of these B-vitamins differentiates it from basic B-complex supplements, focusing its utility toward nerve health.

General Purpose: Why is Bevidox Classified as a Neurotropic Agent?

The classification as a neurotropic agent reflects the medicine's overall purpose: to provide highly concentrated biochemical support for the nervous system’s structural integrity and function. B-vitamins play a fundamental role in maintaining nerve health and are utilized to address requirements where nerve function is compromised. The general utility of Bevidox is therefore to support nerve health and address the body’s increased demands for these crucial B-vitamins, aiding processes like energy metabolism facilitation and nerve regeneration and protection.

Regulatory References

  1. MedlinePlus on B-Vitamins

What side effects are possible with Bevidox?

Possible Side Effects and Safety Information

The official safety profile for Bevidox, the combination of Thiamine (B1), Pyridoxine (B6), and Cyanocobalamin (B12), documents adverse reactions across several System-Organ Classes, consistent with government regulatory classification frameworks.

Adverse Reaction Classifications

The most commonly noted adverse reactions are often mild and transient, including gastrointestinal discomfort like diarrhea or dermatological effects such as rash and itching. Specific frequencies documented in regulatory labeling include:

  • Rare: Severe hypersensitivity reactions, including anaphylactic shock and death, which have been reported following the administration of parenteral B1 or B12.
  • Incidence Not Known: Many effects, including headache, nausea, vomiting, and certain cardiovascular disturbances.

Serious Safety Considerations

The safety documentation highlights a distinction between general adverse reactions and clinically significant events. Serious adverse reactions that have been officially documented include peripheral neuropathy, particularly associated with the chronic, high-dose administration of Pyridoxine (Vitamin B6). Furthermore, cardiovascular complications like pulmonary edema and congestive heart failure have been reported, sometimes occurring early in Vitamin B12 therapy.

Population-Specific Constraints

Specific safety contraindications exist for certain patient groups. Cyanocobalamin is strictly contraindicated in patients with Leber's Hereditary Optic Neuropathy due to the risk of severe optic nerve atrophy. Use is also restricted in individuals with known cobalt hypersensitivity or pre-existing hypervitaminosis.

Overdose and Emergency Response

Overdose and when to seek help

Bevidox is a product typically containing B vitamins. As B vitamins are water-soluble, acute overdose is generally rare from food sources and often occurs due to excessive, long-term intake of high-dose supplements.

Overdose presentations are generally linked to the specific B vitamin taken in excess, such as:

  • Vitamin B6 (Pyridoxine): Prolonged high doses, often well above 200 mg daily, have been associated with sensory neuropathy. Symptoms can include numbness, tingling, or a burning sensation, usually starting in the hands and feet.
  • Niacin (Vitamin B3): Very high doses may cause flushing, itching, gastrointestinal distress, and potentially liver damage with chronic use.
  • Vitamin B12: While generally considered safe in excess, very high intake can rarely cause mild symptoms such as headaches, nausea, or acne-like rashes.

When to seek immediate medical help:

Any time a large quantity of a supplement is ingested—especially if it contains other components like iron or calcium—or if severe symptoms arise, immediate medical attention is required. You should seek urgent care if you experience:

  • Severe confusion, irregular or rapid heartbeat, or difficulty breathing.
  • New or worsening symptoms like persistent numbness, tingling, or muscle weakness.

In all cases of suspected overdose or poisoning, professional medical guidance should be obtained right away. The specific risk profile is highly dependent on the exact ingredients and concentration of the product.

Therapeutic Uses of Bevidox

What Bevidox Treats: Main Uses and Benefits

Bevidox is relevant for managing symptoms related to systemic imbalance and symptoms of increased neurological activity, often in situations involving specific nutritional shortfalls. These essential nutrients support the body's processes related to nerve health and energy utilization.

The medication is commonly used to help with chronic nerve and sensory discomfort, such as persistent tingling and numbness, and is relevant for easing symptoms related to chronic physical weakness and fatigue. It is applied across domains where additional symptomatic support is needed, such as in conditions presenting with recurrent or episodic manifestations.

“Bevidox provides supportive relief in contexts where additional management of discomfort is required.”

The overall benefit is that the medication provides supportive relief that helps ease the overall symptom burden, assists with maintaining general well-being during symptomatic phases, and contributes to improved day-to-day comfort. It is applicable in scenarios where symptoms create noticeable physiological strain and may help patients cope more steadily with symptom fluctuations.


Quick Fact: Relief for Nerve & Energy Symptoms

Bevidox may assist with managing symptoms of chronic fatigue and nerve discomfort in patients with specific metabolic needs.

Regulatory References

  1. NIH MedlinePlus overview on B Vitamins

Eligibility and Restrictions for Use

The eligibility for using Bevidox (methylcobalamin/Vitamin B12) is strictly governed by regulatory classifications, primarily focusing on contraindications and specific patient groups.

Contraindicated Populations (Must Not Use):

  • Patients with known hypersensitivity or allergy to methylcobalamin or any ingredient in the product formulation.
  • Individuals with Leber's hereditary optic atrophy (an eye disease), as use is contraindicated due to the risk of severe and swift optic nerve damage.

Condition-Based Eligibility and Limitations:

  • Use is forbidden in patients with undiagnosed megaloblastic anemia because the treatment can mask an underlying folate deficiency, which may lead to irreversible neurological injury if not treated properly.

Use in Specific Populations:

  • Adults are the primary established user group.
  • Pediatric use (children under 11 years) may be explicitly stated as not established for safety and effectiveness in all non-deficiency settings.
  • Pregnancy and Lactation: Use during pregnancy is generally reserved for treating a confirmed maternal B12 deficiency. The drug is excreted in breast milk, and use during lactation requires careful consultation to weigh maternal benefits against potential infant risks.

Usage requires a confirmed diagnosis of B12 deficiency and careful monitoring for underlying conditions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Bevidox is a combination of Vitamin B1, B6, and B12, and its official interaction profile is defined by specific effects related to each component. Co-administration of the Pyridoxine (B6) component is contraindicated with Levodopa unless the latter is combined with a decarboxylase inhibitor, due to the antagonistic action of Pyridoxine. The Cyanocobalamin (B12) component is not recommended for use in patients with early Leber's disease.

Interactions often involve reduced absorption of B12. Agents such as H2 blockers, PPIs (e.g., Omeprazole), Colchicine, and certain Anticonvulsants may impair B12 absorption. Conversely, co-administration with B6 may lead to decreased plasma concentrations of certain Anticonvulsants. Furthermore, B12 absorption can be affected by chronic heavy alcohol intake.

Chemical incompatibilities define additional restrictions: large doses of Ascorbic Acid (Vitamin C) must be separated by at least one hour from oral B12 administration to prevent chemical inactivation. The B1 and B6 components may also decrease the activity of certain antibiotics. For the injectable form, Thiamine is physically incompatible with alkaline solutions when mixed intravenously.

Mechanism of Action

Mechanism of Action: Neural Cofactor Supply

Bevidox, a combination of neurotropic B vitamins, acts by supplying high concentrations of essential cofactors to critical cellular pathways within the nervous system. The mechanism is tripartite, addressing energy, signaling, and structure simultaneously.

Thiamine (B1) is converted to Thiamine Diphosphate (TDP), an indispensable cofactor for enzymes like the pyruvate dehydrogenase complex (PDHC) in neuronal mitochondria. This action enables the metabolic production of Adenosine Triphosphate (ATP), influencing the cellular resources required for stable nerve impulse conduction and the maintenance of membrane potential.

Pyridoxine (B6) is metabolized to Pyridoxal 5'-Phosphate (PLP), which serves as a necessary cofactor for key decarboxylases and aminotransferases. These enzymes mediate the synthesis of regulatory neurotransmitters (e.g., GABA and Serotonin). This targeted supply influences pathways associated with the balance of inhibitory and modulatory signaling and the regulation of afferent signaling.

Cobalamin (B12), as Methylcobalamin, acts as a vital cofactor for methionine synthase (MTR). MTR is essential for generating precursors required for the biosynthesis of components that constitute the protective myelin sheath. This mechanism provides necessary cofactors for myelin structural integrity and the maintenance of the axon.

Dosage and Administration Information

How to use Bevidox — Official Administration Guidelines

Bevidox is an oral capsule used for the prevention of thromboembolic complications in certain adult patients. It is essential to follow the specific dosing and administration schedule to ensure proper use. The medication must be taken for the full prescribed duration of 35 to 42 days.


Dosing and Administration Protocol

Administration Element Standard Adult Dose Dose for Severe Renal Impairment* or P-gp Inhibitor Concomitant Use
Initial Single Dose 160 mg 80 mg
Maintenance Dose 80 mg once daily 40 mg once daily
Route & Timing Oral capsule, taken with food Oral capsule, taken with food
Frequency Once daily, at the same time each day Once daily, at the same time each day

Procedural and Missed Dose Instructions

  1. Begin treatment with the initial single dose on the first day.
  2. Starting on the next day, take the maintenance dose once daily with food.
  3. Ensure the daily dose is taken at the same time each day throughout the 35–42 day treatment course.
  4. If a dose is missed, it should be taken as soon as possible on the same day. Do not double the dose to make up for the missed one.
  • Severe Renal Impairment is defined as a Creatinine Clearance (CrCl) ≥ 15 to < 30 mL/min.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Bevidox

Evidence for Supportive Use in Peripheral Neuropathy and Nerve Discomfort

Bevidox, the combination of B1, B6, and B12, was studied for use in populations where outcomes related to physical discomfort arising from peripheral nerve issues were studied, such as tingling, numbness, or nerve pain. Research has included Randomized Controlled Trials (RCTs) which explored outcomes when the combination was compared against a placebo, and Systematic Reviews that combine data from multiple clinical studies. Studies examined patient-reported outcomes (like symptom scores) and objective measures (like Nerve Conduction Velocity) in adults with mild to moderate peripheral nerve issues. Findings describe the changes in symptom patterns that were observed, but results have been mixed across different research due to the heterogeneity of nerve conditions studied.


Evidence for Addressing Confirmed B-Vitamin Deficiency

The combination was studied for use in individuals with confirmed deficiency of B1, B6, and/or B12. This research is generally high-level, relying on Nutritional Intervention Studies and Systematic Reviews. Research explores the relationship between the administration of high-dose vitamins and the normalization of blood biomarkers (like homocysteine), along with the documentation of deficiency-related manifestations. This combination is documented in medical literature in the context of specific nutritional gaps.


Research on Long-Term Use and Key Gaps

Research includes studies that explored follow-up periods ranging from short-term assessments up to six months or longer. However, long-term effects are not fully established, as many core studies are not structured for extended observation necessary to characterize long-term status or prevention of recurrence. Certainty remains low in areas lacking modern, large-scale RCTs, particularly regarding broad neuromuscular pain indications and comparison to newer supportive care. Research provides context but not individual predictions, highlighting what is known and what is still uncertain.

Key Studies & References

  1. Vitamin B12 Deficiency: Symptoms, Causes & Treatment (Covers deficiency and associated neurological symptoms)

Frequently Asked Questions (FAQ)

Common questions about Bevidox (FAQ)


Q: Is it true that Bevidox can sometimes cause mild stomach upset?

Official documentation notes that gastrointestinal discomfort, such as diarrhea, is among the commonly observed adverse reactions. Other effects, like nausea and vomiting, are also documented, although their frequency is not known in all cases. These effects are described as often mild and temporary.


Q: If I feel dizzy after using Bevidox, is that considered a serious side effect?

The documentation highlights specific serious adverse events, such as anaphylactic shock (a severe allergic reaction) and peripheral neuropathy (nerve damage) associated with the chronic, high-dose use of the B6 component. Dizziness is documented in safety information under effects where the incidence is not known.


Q: What are the reasons someone would be told not to use Bevidox?

The product is officially contraindicated in patients with Leber's Hereditary Optic Neuropathy, known cobalt hypersensitivity, or pre-existing hypervitaminosis (excessive vitamin levels). Official documentation also indicates that certain pre-existing conditions, such as severe renal (kidney) impairment or chronic alcohol intake, may require discussion regarding use or dose modification.


Q: Is it possible to be allergic to Bevidox?

Yes, official safety documents list severe hypersensitivity reactions, including anaphylactic shock, which have been reported following the administration of the components in this product. These events are documented as rare but serious.


Q: Can people with kidney conditions use Bevidox?

Official administration guidelines include a modified dose for individuals with severe renal impairment. This means that official guidelines provide a specific dose for this condition in the prescribing information.


Q: What kind of warnings exist for combining Bevidox with alcohol?

Official documentation notes that chronic heavy alcohol intake can negatively affect the absorption of the Vitamin B12 component of Bevidox. This regulatory statement indicates the potential for reduced intended effect.


Q: Why is the official purpose of Bevidox sometimes misunderstood by the public?

Official research documentation describes the combination in the context of both supportive use for peripheral nerve issues and for addressing confirmed B-vitamin deficiency. These two distinct official uses may lead to public confusion regarding the product's primary goal.


Q: Why do some people call Bevidox a 'vitamin' while others call it a 'drug'?

Bevidox is a combination of B vitamins that functions by supplying essential cofactors to the nervous system. The product is regulated as a pharmaceutical with specific administration protocols, established safety information, and formal indications outlined in official documents.


Q: Is Bevidox considered safe for long-term use?

Official research summaries indicate that long-term effects have not been fully established, as many core studies were not structured for extended observation. Additionally, chronic, high-dose administration of the Pyridoxine (B6) component is officially associated with the serious adverse reaction of peripheral neuropathy (nerve damage).


Q: Are there studies published that look at the long-term safety of Bevidox?

Official overviews of the research state that studies have included follow-up periods ranging up to six months or longer. The summaries also indicate that long-term effects have not been fully established, as many studies were not structured for the extended observation necessary to characterize long-term status.


Q: What are the signs of using 'too much' Bevidox?

The safety documentation warns against use in individuals with pre-existing hypervitaminosis (excessive vitamins). More importantly, chronic, high-dose use of the Vitamin B6 component is specifically documented as a cause of peripheral neuropathy, which is a condition involving the nerves.


Q: Is the research for Bevidox mostly from animal studies or human trials?

The official overview of research evidence cites human trial types, including Randomized Controlled Trials (RCTs), Systematic Reviews, and Nutritional Intervention Studies. These are all forms of human clinical trials.


Q: What happens if Bevidox is exposed to heat or light?

Official labeling specifies that the product must be stored at Controlled Room Temperature to maintain its potency. This storage requirement suggests that exposure to excessive heat or light may compromise the quality and intended potency of the product.


Q: Why does the packaging for Bevidox warn about certain pre-existing conditions?

Official warnings and contraindications exist because certain pre-existing conditions, such as Leber's Hereditary Optic Neuropathy or impaired kidney function, can alter how the B-vitamin components are metabolized and affect the product's overall safety profile.

How should Bevidox be stored and disposed of?

How to Store Bevidox

Bevidox must be stored strictly according to its official labeling to maintain its potency. The product should be kept at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F).

It is mandatory to protect the medicine from light and to keep the container tightly closed. The medicine must not be frozen. As a universal safety measure for all medications, Bevidox must be kept out of the sight and reach of children.

Disposal of Bevidox

Unused or expired Bevidox should be disposed of via an official drug take-back program. If such a program is not available, the medicine must be mixed with an undesirable substance (such as used coffee grounds) and placed in a sealed container for household trash. The medication must not be poured down a sink or flushed down a toilet unless explicitly instructed by a government regulator.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Bevidox found in:

A-Z Index: